Condition
no Condition, Basic Science
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Withdrawn1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06904521CompletedPrimary
OH Baseline Research Study
NCT07508722Not ApplicableNot Yet Recruiting
Transcranial Ultrasonic Neuromodulation of Primary Visual Cortex and Primary Auditory Cortex in Humans
NCT06768723Not ApplicableCompletedPrimary
Effects of Post-activation Performance Enhancement Protocols on Judo-specific Performance: a Randomized Crossover Trial
NCT03416569Not ApplicableWithdrawnPrimary
Effects of Prazosin on the Attention-Enhancing Effects of Nicotine
Showing all 4 trials